2023 Annual Conference

09/18/2023 - 09/20/2023

Chicago, IL

IHFDA 7th Annual Conference

This event is a Hybrid event

***Hotel Update – The Westin O’Hare is Sold Out on 9/19. The hotel directly across the street is Chicago Marriott Suites O’Hare. Information about the Marriott can be found here.

IHFDA is pleased to announce the 2023 annual conference this year in the Chicago area. The dates are September 18-20, 2023 at the Chicago Westin O’Hare in Rosemont, Illinois.

As in the past, the agenda will be packed full of the most up-to-date information on the diversion of medications in healthcare facilities. Look for a full agenda soon along with exhibitor opportunities.

IHFDA will also be offering the Fundamental Drug Diversion Course this year after the large attendance and positive feedback in 2022. In addition, the course is being improved with updated and additional training content within the diversion space. More information is available below.

The conference is available as in-person or hybrid, the diversion course is virtual with a live (in-person & virtual) Q&A with the panel.

Conference Registration Speaker / Corporate Registration Exhibitor Information

Fundamental Drug Diversion Certificate

The IHFDA Executive Board is proud to once again offer the fundamental course on drug diversion inside healthcare facilities. This groundbreaking 8-hour compilation of some of the most experienced and trusted experts in this field should prove extremely helpful whether you are just starting to seriously look at drug diversion inside your institution or you have been doing it for several years.

IHFDA has updated and added new training content from last year, and we feel that this course will address the main concerns of everyone who is tasked with these crucial investigations, with the ability to ask questions of the actual presenters. The presenters are either currently working on drug diversion inside a healthcare facility, or have spent many years in the field.

This is something many of you in the field have been asking for years to be available for your new people into this area of investigation and those who desire a refresher course while also seeing the most recent methods and means of today’s investigators.

The first offering of this course will provide continuing education credits. The cost for the virtual course is $200.

Fundamental Drug Diversion Certificate Agenda

“Drug Diversion: Personal Impacts, Patient Harm and Unexpected Outcomes” (1 hour)

“Overview of Institutional Drug Diversion” (1 hour)

“Drug Diversion Interviews in Healthcare: Gateway to the Truth” (1 hour)

“The Public Health Perspective: Injectable Drug Diversion and Bloodborne Pathogens Transmission” (1 hour)

“Developing a Comprehensive Drug Diversion Monitoring Program” (3 hours)

“The Intersection of Peer Support and Substance Use Disorder in Nurses” (1 hour)

Learn more about this course

Conference Agenda

**ALL TIMES LISTED ARE CENTRAL TIME ZONE

Download Agenda

**Agenda is subject to change**

8:00 A.M. - 9:00 A.M.

FUNDAMENTAL DRUG DIVERSION CERTIFICATE PANEL DISCUSSION & FINAL REMARKS

**Attendance is restricted to certificate participants only**
No CEs awarded for this session

9:15 A.M. - 9:30 A.M.

WELCOME AND OPENING REMARKS – START OF ANNUAL CONFERENCE

9:30 A.M. – 10:30 A.M.

CATCH ME (IF YOU CAN): THE IMPAIRED PROVIDER

Rodrigo Garcia, MBA, MSN, APN-BC, CRNA, Parkdale
Claudia Garcia, MBA, BSN, CADAC II, LAC, Parkdale

10:30 A.M. – 11:30 A.M.

DETAILS MATTER: ASHP CONTROLLED SUBSTANCES DIVERSION GAP – ASSESSMENT TOOL TO MITIGATE RISK

Mary Nelson, MSN, RN, HonorHealth
JoAnne Myhre, CPhT, FMSHP, BA, Allina Health

11:30 A.M. – 12:15 P.M.

Lunch & Time with Exhibitors

12:15 P.M. – 1:15 P.M.

DIVERSION: THE EMOTIONAL CONNECTION INTERVIEW

Kevin Vanover, Protective Services Investigator, TriHealth

1:15 P.M. – 2:15 P.M.

IMPLEMENTATION OF A TARGETED WASTE TESTING PROGRAM IN TWO LARGE ACADEMIC HEALTH SYSTEMS

Amisha Arya, PharmD, BCSCP, CJCP, NYU Langone Health
Jorie Frasiolas, PharmD, BCPS, NewYork-Presbyterian
Nhan Cho, PharmD, NewYork-Presbyterian

2:15 P.M. – 3:00 P.M.

POSTERS & TIME WITH EXHIBITORS

3:00 P.M. – 4:00 P.M.

PARTNERING FOR PATIENT SAFETY – EXPLORING THE ROLE OF INFECTION PREVENTION IN A DRUG DIVERSION INVESTIGATION

Amanda Hays, PharmD, MHA, BCPS, CPHQ, DPLA, FASHP, Becton, Dickinson Company
Rachael Snyders, MPH, BSN, RN, CIC, FAPIC, Becton, Dickinson Company

4:00 P.M. – 5:15 P.M

WOULD YOU RAISE YOUR HAND?

Moderator: Rodrigo Garcia
Terri Vidals, BS Pharm, Rxpert Solutions
Mary Nelson, MSN, RN, CPPS, HonorHealth
Alecia Pittman, BSN, RN, BA, Cooper Health
Kristin Waite-Labott, BSN, RN, BA, Freedom Institute

5:15 P.M. – 6:30 P.M.

NETWORKING / SOCIAL HOUR & TIME WITH EXHIBITORS

Drinks and hors d’oeuvres – In The Exhibitor Hall

6:00 P.M. - 9:00 P.M.

Free Shuttle to the entertainment District

Will be in the front of the hotel

8:15 A.M. – 9:00 A.M.

IHFDA MEMBERSHIP MEETING AND COMMITTEE UPDATES

9:00 A.M. – 10:00 A.M.

DEA INSPECTIONS: WHAT’S COMPLIANCE GOT TO DO WITH IT?

Joseph Nguyen, PharmD, MBA, CHC, CPPS, UT Southwestern Medical Center
Elizabeth Daniel, PharmD, BCPS, BCCCP, UT Southwestern Medical Center

10:00 A.M. – 11:15 A.M.

DIVERSION HAPPENS IN HAPPY PLACES TOO: PEDIATRIC PERSPECTIVES IN DIVERSION PROGRAMS

Karen Lettre, MSN, RN, Texas Children’s Hospital
Lacey Rodgers, PharmD, MHA, BCSCP, St. Louis Children’s Hospital
Heidi McNeely, PhD, RN, PCNS-BC, Children’s Hospital Colorado

11:15 A.M. – 12:00 P.M.

LUNCH & TIME WITH EXHIBITORS

12:00 P.M. – 1:15 P.M.

DRUG DIVERSION DETECTION AND PREVENTION IN THE HOSPITAL PHARMACY DEPARTMENT

Moderator: Samantha Bastow, PharmD, MBA, Becton Dickinson
Anthony Scott, PharmD, MBA, Emory University Hospital
Nathan Mills, PharmD, CPPS, Appalachian Regional Health
Alex Raymond, PharmD, MS, CHC, Ochsner Health

1:15 P.M. – 2:15 P.M.

ACROSS STATE LINES: EFFECTIVELY LEADING A MULTI-STATE MEDICATION DIVERSION PREVENTION PROGRAM

Alissa Voils, PharmD, MSHA, Mayo Clinic

2:15 P.M. – 3:00 P.M.

POSTER PRESENTER SESSION & BREAK

3:00 P.M. – 4:00 P.M.

ASSESSING AND TREATING ADDICTION: SHEDDING BLINDERS AND UTILIZING PRACTICAL APPROACHES

Anish John MD, ABPN, ABPM, Associate Medical Director, Positive Sobriety Institute

4:00 P.M. – 5:00 P.M.

BEYOND THE INVESTIGATION – DEVELOPING DEFINED PROCESSES FOR MULTIDISCIPLINARY COORDINATION PRE- AND POST-EMPLOYEE INTERVIEW

Cory Luper, BA, Atrium Health Wake Forest Baptist
Leah Mitchell, PharmD, MBA, Atrium Health Wake Forest Baptist

6:30 P.M. - 9:30 P.M.

Free Shuttle to the entertainment District

Will be in the front of the hotel

7:00 A.M. – 7:50 A.M.

VENDOR BREAKFAST

8:00 A.M. – 8:50 A.M.

When You Get the Call: Launching a suspected diversion investigation

Sharron Coffie MSN, RN, CNS, UT Southwestern Medical Center

9:00 A.M. – 10:00 A.M.

NON-CONTROLLED DRUG DISCREPANCY REPORTS (IF YOU’RE NOT LOOKING, YOU DON’T KNOW WHAT YOU’RE MISSING!)

Stephen Webster, PharmD, MSBA, University of Rochester Medical Center

10:00 A.M. – 10:15 A.M.

Break

10:15 A.M. – 11:15 A.M.

THE ROUST JOURNEY: IMPLEMENTING AN OPIOID STEWARDSHIP PROGRAM IN A HEALTH SYSTEM

Michael Dejos, PharmD, MBA, BCPS, CHOP, LSSBB, DPLA, Methodist Le Bonheur Healthcare

11:15 A.M. – 12:30 P.M.

Education as Part of a Comprehensive Diversion Program

Amisha Arya PharmD, BCSCP, CJCP – NYU Langone Health
Evan Frasure III PharmD, BCPS – Duke University Health System
Greg Griffin CPhT – Mayo Clinic

12:30 P.M. – 12:40 P.M.

CLOSING REMARKS

ADDRESSING UNRESOLVED CONTROLLED SUBSTANCE DISCREPANCIES AND INCREASING THE NUMBER OF CONTROLLED SUBSTANCE DISPENSES FROM AUTOMATED DISPENSING CABINETS

Andreece Gandy, PharmD, MBA, Methodist Le Bonheur Hospital – North

AI BIAS CONSIDERATIONS IN DRUG DIVERSION DETECTION AND PREVENTION PROGRAMS

Samantha Bastow,PharmD, MBA

MEASURING PROGRAM SUCCESS THROUGH KEY PERFORMANCE INDICATORS

Danielle Neal PharmD, MBA, BCPS, CPEL
Leah Mitchell PharmD, MBA, Atrium Health Wake Forest Baptist

OPIOID SAFETY AWARENESS 101: GETTING BACK TO THE BASICS!

Summera Zaheer, MHA, CLSSGB
Sharron Coffie, MSN, RN, CNS, UT Southwestern Medical Center

SAFEGUARDING MEDICATION RISK BY REDUCING OVERRIDES

Nic Jenkins, BSHA, AAS, CPhT
Heidi McNeely, PhD, RN, PCNS-BC, Children’s Hospital Colorado

TIMELINE OF DEVELOPMENT FOR A SYSTEM DRUG DIVERSION PROGRAM: PAST, PRESENT, AND FUTURE

Bailey Eason, PharmD, MS, BCPS
Jennifer Wooten, BS, PharmD, BCPS
Kristen March, BS, PharmD, BCPS, Northwestern Medicine

TRAVEL NURSES AT A TRAVEL DESTINATION

Amina Luzic, PharmD, RPh

WHICH DRUG DIVERSION MONITORING APPROACH REIGNS SUPREME? A RETROSPECTIVE STUDY TO COMPARE THE OUTCOMES OF REPORT-BASED AND CASE-BASED DIVERSION MONITORING

Adam Beeler, PharmD, MS, Protenus

Conference Exhibitors (A-Z)